166 related articles for article (PubMed ID: 18439253)
1. Circulating alpha1-antitrypsin in the general population: determinants and association with lung function.
Senn O; Russi EW; Schindler C; Imboden M; von Eckardstein A; Brändli O; Zemp E; Ackermann-Liebrich U; Berger W; Rochat T; Luisetti M; Probst-Hensch NM;
Respir Res; 2008 Apr; 9(1):35. PubMed ID: 18439253
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of alpha-1-antitrypsin levels in blood serum of patients with chronic obstructive pulmonary disease.
Perincek G; Avcı S
Acta Biomed; 2018 Oct; 90(1):37-43. PubMed ID: 30889153
[TBL] [Abstract][Full Text] [Related]
3. Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population.
Janciauskiene S; DeLuca DS; Barrecheguren M; Welte T; Miravitlles M; ;
Arch Bronconeumol (Engl Ed); 2020 Feb; 56(2):76-83. PubMed ID: 31153743
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
5. Serum levels and genotype distribution of α1-antitrypsin in the general population.
Ferrarotti I; Thun GA; Zorzetto M; Ottaviani S; Imboden M; Schindler C; von Eckardstein A; Rohrer L; Rochat T; Russi EW; Probst-Hensch NM; Luisetti M
Thorax; 2012 Aug; 67(8):669-74. PubMed ID: 22426792
[TBL] [Abstract][Full Text] [Related]
6. SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations.
Zorzetto M; Russi E; Senn O; Imboden M; Ferrarotti I; Tinelli C; Campo I; Ottaviani S; Scabini R; von Eckardstein A; Berger W; Brändli O; Rochat T; Luisetti M; Probst-Hensch N;
Clin Chem; 2008 Aug; 54(8):1331-8. PubMed ID: 18515255
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
8. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
9. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
Calle Rubio M; Soriano JB; López-Campos JL; Soler-Cataluña JJ; Alcázar Navarrete B; Rodríguez González-Moro JM; Miravitlles M; Barrecheguren M; Fuentes Ferrer ME; Rodriguez Hermosa JL;
PLoS One; 2018; 13(6):e0198777. PubMed ID: 29953442
[TBL] [Abstract][Full Text] [Related]
10. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
11. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
[TBL] [Abstract][Full Text] [Related]
12. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
13. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK
Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752
[TBL] [Abstract][Full Text] [Related]
14. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.
Guerra S; Halonen M; Vasquez MM; Spangenberg A; Stern DA; Morgan WJ; Wright AL; Lavi I; Tarès L; Carsin AE; Dobaño C; Barreiro E; Zock JP; Martínez-Moratalla J; Urrutia I; Sunyer J; Keidel D; Imboden M; Probst-Hensch N; Hallberg J; Melén E; Wickman M; Bousquet J; Belgrave DC; Simpson A; Custovic A; Antó JM; Martinez FD
Lancet Respir Med; 2015 Aug; 3(8):613-20. PubMed ID: 26159408
[TBL] [Abstract][Full Text] [Related]
15. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants.
Ottaviani S; Gorrini M; Scabini R; Kadija Z; Paracchini E; Mariani F; Ferrarotti I; Luisetti M
Transl Res; 2011 Jun; 157(6):332-8. PubMed ID: 21575917
[TBL] [Abstract][Full Text] [Related]
16. HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin.
Thudium RF; Lundgren J; Benfield T; Nordestgaard BG; Borges ÁH; Gerstoft J; Nielsen SD; Ronit A;
HIV Med; 2018 Nov; 19(10):745-750. PubMed ID: 30160349
[TBL] [Abstract][Full Text] [Related]
17. α
Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
[TBL] [Abstract][Full Text] [Related]
19. Airway hyperresponsiveness in a large group of subjects with alpha1-antitrypsin deficiency: a cross-sectional controlled study.
Malerba M; Radaeli A; Ceriani L; Tantucci C; Grassi V
J Intern Med; 2003 Mar; 253(3):351-8. PubMed ID: 12603503
[TBL] [Abstract][Full Text] [Related]
20. alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants.
Senn O; Russi EW; Imboden M; Probst-Hensch NM
Eur Respir J; 2005 Nov; 26(5):909-17. PubMed ID: 16264055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
